Vanguard Group’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Sell |
|
|||||
|
2025
Q1 | $14.1M | Sell |
|
|||||
|
2024
Q4 | $23.9M | Buy |
|
|||||
|
2024
Q3 | $29M | Buy |
|
|||||
|
2024
Q2 | $23.6M | Buy |
|
|||||
|
2024
Q1 | $35.7M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Buy |
|
|||||
|
2023
Q3 | $11.3M | Buy |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $17.5M | Buy |
|
|||||
|
2022
Q4 | $9.74M | Buy |
|
|||||
|
2022
Q3 | $4.8M | Buy |
|
|||||
|
2022
Q2 | $1.51M | Sell |
|
|||||
|
2022
Q1 | $3.57M | Hold |
|
|||||
|
2021
Q4 | $2.87M | Sell |
|
|||||
|
2021
Q3 | $4.9M | Buy |
|
|||||
|
2021
Q2 | $1.71M | Sell |
|
|||||
|
2021
Q1 | $2.52M | Buy |
|
|||||
|
2020
Q4 | $1.76M | Buy |
|
|||||
|
2020
Q3 | $5.03M | Buy |
|
|||||
|
2020
Q2 | $4.79M | Buy |
|
|||||
|
2020
Q1 | $2.81M | Buy |
|
|||||
|
2019
Q4 | $2.49M | Hold |
|
|||||
|
2019
Q3 | $2.28M | Buy |
|
|||||
|
2019
Q2 | $3.35M | Buy |
|
|||||
|
2019
Q1 | $2.83M | Buy |
|
|||||
|
2018
Q4 | $1.08M | Sell |
|
|||||
|
2018
Q3 | $2M | Sell |
|
|||||
|
2018
Q2 | $2.42M | Buy |
|
|||||
|
2018
Q1 | $1.06M | Buy |
|
|||||
|
2017
Q4 | $829K | Buy |
|
|||||
|
2017
Q3 | $721K | Buy |
|
|||||
|
2017
Q2 | $337K | Sell |
|
|||||
|
2017
Q1 | $590K | Buy |
|
|||||
|
2016
Q4 | $810K | Sell |
|
|||||
|
2016
Q3 | $1.38M | Buy |
|
|||||
|
2016
Q2 | $504K | Sell |
|
|||||
|
2016
Q1 | $734K | Buy |
|
|||||
|
2015
Q4 | $1.03M | Buy |
|
|||||
|
2015
Q3 | $913K | Buy |
|
|||||
|
2015
Q2 | $1.07M | Buy |
|